➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
McKinsey
Moodys
Colorcon
McKesson

Last Updated: June 20, 2021

DrugPatentWatch Database Preview

RAPACURONIUM BROMIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rapacuronium bromide and what is the scope of patent protection?

Rapacuronium bromide is the generic ingredient in one branded drug marketed by Organon Usa Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for RAPACURONIUM BROMIDE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 18
Patent Applications: 441
DailyMed Link:RAPACURONIUM BROMIDE at DailyMed

US Patents and Regulatory Information for RAPACURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-002 Aug 18, 1999 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-001 Aug 18, 1999 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for RAPACURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-001 Aug 18, 1999   Try Before You Buy   Try Before You Buy
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-002 Aug 18, 1999   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Mallinckrodt
Moodys
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.